Should be a double from here in 2019. More production and profits validation, updates on expansions and perhaps ownership increases. Pretty deep value at the moment.
Not sure if they will raise capital or increase borrowing capacity. Prefer less dilution for sure at our current valuation.
- Forums
- ASX - By Stock
- CIA
- Ann: Canadian Document Filing- Press Release Q2 Results 2018-2019
Ann: Canadian Document Filing- Press Release Q2 Results 2018-2019, page-6
Featured News
Add CIA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.53 |
Change
0.040(0.73%) |
Mkt cap ! $2.994B |
Open | High | Low | Value | Volume |
$5.60 | $5.69 | $5.53 | $5.001M | 897.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3359 | $5.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.54 | 26158 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 27838 | 5.380 |
2 | 12741 | 5.370 |
1 | 9762 | 5.360 |
1 | 2000 | 5.290 |
1 | 5 | 5.280 |
Price($) | Vol. | No. |
---|---|---|
5.440 | 9760 | 1 |
5.450 | 14762 | 2 |
5.480 | 14585 | 2 |
5.490 | 15487 | 1 |
5.500 | 16813 | 1 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
CIA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online